EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems

Rayna Georgieva Bryaskova iD, Krasimir Georgiev Staykov, Damyan Stoyanov Ganchev

Pharmaceutics · 29.01.2026 · 18 (2) · 177

DOI: 10.3390/pharmaceutics18020177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.01.2026. Verfasst von Rayna Georgieva Bryaskova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymer Engineering, University of Chemical Technology and Metallurgy, 1000 Sofia, Bulgaria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation EU, European Union-Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymeric micelles have become a versatile and clinically significant class of nanocarriers for cancer therapy. They effectively solubilize poorly water-soluble anticancer drugs, extend their circulation in the bloodstream, and promote accumulation in tumors. Early studies focused on conventional PEG-based polymeric micelles that utilize passive targeting based on the enhanced permeability and retention (EPR) effect, with several of these advancing to clinical trials. Active targeting strategies using modified polymer micelles with various targeting ligands have been introduced to enhance cellular uptake and improve tumor specificity. Recently, the field has shifted toward smart polymer micelles that can respond to both internal (endogenous) and external (exogenous) stimuli. These stimuli-responsive systems enable controlled drug release, enhance delivery inside cells, and improve therapeutic effectiveness, all while reducing systemic toxicity. This review summarizes recent advancements in polymer design, drug-loading techniques, preparation methods, and targeting strategies for polymeric micelles, highlighting both preclinical progress and systems that have reached clinical stages. The transition from conventional to smart polymer micelles is a significant advancement toward achieving more precise, effective, and personalized cancer nanomedicine.

Schlagwörter

Stichwörter der Autor:innen

cancer therapychemotherapeuticsdrug releasenanomedicinepolymer micelles

Autor:innen und Institutionen

  • Department of Polymer Engineering, University of Chemical Technology and Metallurgy, 1000 Sofia, Bulgaria.
  • Department of Machine Elements and Non-Metal Constructions, Technical University of Sofia, 1000 Sofia, Bulgaria.

ORCID-Profile: Rayna Georgieva Bryaskova

Förderung

  • Next Generation EU
  • European Union-Next Generation EU

Zitieren

APA

Bryaskova, R. G., Staykov, K. G., & Ganchev, D. S. (2026). Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems. Pharmaceutics, 18(2), 177. https://doi.org/10.3390/pharmaceutics18020177

Vancouver

Bryaskova RG, Staykov KG, Ganchev DS. Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems. Pharmaceutics. 2026;18(2):177. doi:10.3390/pharmaceutics18020177

BibTeX
@article{Bryaskova2026,
  author = {Bryaskova, Rayna Georgieva and Staykov, Krasimir Georgiev and Ganchev, Damyan Stoyanov},
  title = {Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {177},
  doi = {10.3390/pharmaceutics18020177}
}
Kostenlos starten →